ANNUNZIATA, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 9.938
EU - Europa 6.719
AS - Asia 1.120
OC - Oceania 26
SA - Sud America 21
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.849
Nazione #
US - Stati Uniti d'America 9.904
GB - Regno Unito 1.884
IE - Irlanda 862
IT - Italia 836
CN - Cina 824
DE - Germania 794
UA - Ucraina 709
SE - Svezia 518
RU - Federazione Russa 378
FR - Francia 367
SG - Singapore 201
FI - Finlandia 157
ES - Italia 122
TR - Turchia 45
CA - Canada 30
BE - Belgio 24
AU - Australia 18
BR - Brasile 16
CI - Costa d'Avorio 11
NL - Olanda 10
RO - Romania 9
NZ - Nuova Zelanda 8
PL - Polonia 8
EU - Europa 7
HK - Hong Kong 7
IN - India 7
CZ - Repubblica Ceca 6
EE - Estonia 5
HR - Croazia 4
IL - Israele 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
DK - Danimarca 3
HU - Ungheria 3
PK - Pakistan 3
AZ - Azerbaigian 2
BD - Bangladesh 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
ID - Indonesia 2
IM - Isola di Man 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 17.849
Città #
Menlo Park 3.024
Southend 1.735
Fairfield 1.018
Dublin 859
Jacksonville 564
Chandler 559
Ashburn 521
Woodbridge 477
Santa Clara 420
Wilmington 413
Seattle 388
Ann Arbor 375
Houston 345
Cambridge 326
Beijing 221
Nanjing 187
Princeton 164
Singapore 140
Málaga 108
Siena 97
Boardman 91
Nanchang 81
Milan 80
Dearborn 79
San Diego 71
Moscow 67
Rome 60
Helsinki 50
Kunming 40
San Mateo 40
Izmir 39
Norwalk 39
Shenyang 38
Hebei 36
New York 36
Florence 31
Tianjin 30
London 28
Jiaxing 25
San Francisco 24
Brussels 22
Changsha 21
Düsseldorf 21
Jinan 19
Venezia 18
Shanghai 16
Turin 15
Hefei 13
Ottawa 13
Toronto 13
Zhengzhou 12
Abidjan 11
Hangzhou 11
Los Angeles 11
Redwood City 11
Falls Church 10
Fucecchio 10
Madrid 10
Ningbo 10
Bologna 9
Guangzhou 9
Palermo 9
Anguillara Sabazia 8
Kilburn 8
Cecina 7
Edinburgh 7
Naples 7
Philadelphia 7
Richland 7
Auburn Hills 6
Auckland 6
Cagliari 6
Changchun 6
Indiana 6
Amsterdam 5
Catania 5
Munich 5
Parma 5
Poggibonsi 5
Saint Louis 5
Saint Petersburg 5
Salerno 5
Sydney 5
Tallinn 5
Tappahannock 5
Vicenza 5
Washington 5
Atlanta 4
Bolzano 4
Canberra 4
Central 4
Chicago 4
Hounslow 4
Lancaster 4
Marino 4
Melbourne 4
Monza 4
Padova 4
Pordenone 4
Prague 4
Totale 13.418
Nome #
Sclerosi multipla e sindrome di Sjogren . Più di una semplice associazione? 473
Meningoencefalite da Listeria e sindrome di Miller-Fisher: un’inusuale associazione 461
Listeria meningoencephalitis and anti-GQ1b antibody syndrome 266
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome 250
Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium 228
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis 228
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 220
Transient supranuclear paresis of the abduction in viral encephalitis of the brainstem 215
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 211
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin? 211
Postpartum relapses increase the risk of disability progression in multiple sclerosis: The role of disease modifying drugs 208
Altered CSF protein pattern in a case of mycosis fungoides with nervous system involvement 205
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 203
Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy 197
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 196
Successful response of non-recovering Ramsay Hunt syndrome to intravenous high dose methylprednisolone 189
Serum beta-2 microglobulin levels and cognitive function in chronic dialysis patients 187
Sindrome di Vogt-Koyanagi-Harada e gestazione. 187
Serum anti-brain endothelium antibodies and cognitive assessment in patients with Binswanger's encephalopathy 186
null 186
ANTIBODIES DIRECTED AGAINST THE MYELIN BASIC PROTEIN RECOGNISING AN EPITOPE OF CD64 AND THEIR USE AS IMMUNOSUPPRESSANT 185
A case of bilateral facial palsy with detection of herpes simplex virus type 1 DNA in the cerebrospinal fluid and serum anti-gm1 antibodies. 184
Expression of tight junction and drug efflux transporter proteins in an in vitro model of human blood-brain barrier 182
Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis 181
Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice 180
Expression of preprotachykinin-A mRNA isoforms and substance P production in T lymphocytes of human healthy subjects 177
Serotonin levels and depression in patients with multiple sclerosis 176
Symptomatic cranial neuralgias in multiple sclerosis: Clinical features and treatment 172
High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort 172
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 170
Clinical-radiologic heterogeneity of occipital neuralgiform pain as multiple sclerosis relapse. 170
Miller-Fisher syndrome following vaccination against influenza virus A/H1N1 in an AIDS patient 169
VII Congress of the Italian Neuroimmunology Group 169
Adrenomyeloneurodystrophy with late cerebral involvement and evidence of a multiple autoimmune disorder 169
Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis 167
Anti-HTLV-I antibodies in the serum and CSF from amyotrophic lateral sclerosis patients: negative findings 164
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 164
Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment 163
Impairment of vertical saccades from an acute pontine lesion in multiple sclerosis 160
Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis 159
Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis 157
Clinical features of Sjogren’s syndrome in patients with multiple sclerosis 157
Higher expression of BDNF receptor gp145trkB is associated with lower apoptosis intensity in T cell lines in multiple sclerosis 156
Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy 155
Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barré syndrome 155
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 155
Idiopathic bilateral facial palsy: is a causative role of anti-GM1 ganglioside and herpes simplex type 1 possible? 153
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 149
Autoimmunitary changes in adrenoleukodystrophy and adrenomyeloneuropathy 149
HIV-1 gp 120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance p 149
Cerebrospinal fluid immunoglobulins and neurologic diseases [Immunoglobuline liquorali e malattie neurologiche] 147
IL-6 detection in multiple sclerosis brain 146
Behçet's disease: an unusual case with bilateral obliterating retinal panarteritis and ischemic optic atrophy 146
Development of cerebellar cells in neuron enriched cultures: cell surface proteins 145
Cerebrospinal fluid markers of demyelination: MBP and anti-brain protein antibodies. 144
Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis 142
Reply to :" Miller Fisher syndrome following vaccination" 142
Increase of predominantly k-type light chains in the CSF of a case of subacute sclerosing panencephalitis treated with interferon 141
Adrenoleukodystrophy: a genetic, clinical, biochemical and computed tomographic study of four patients in three different families 141
Impairment of human brain development: glycoconjugate and lipid changes in congenital athyroidism 141
Study of influence of sex and age on human normal serum lysosomal enzymes by using 4-methylumbelliferyl substrates 140
High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients 139
Breastfeeding is not related to postpartum relapses in multiple sclerosis 139
The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study 138
Effect of aging on the heterosaccharide moiety of glycoproteins: study of concanavalin A-bound glycoproteins and glycosidases 137
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 137
Multiple sclerosis onset after antitetanus toxoid immunoglobulin prophylaxis 136
Brain glycosidases in Creutzfeldt-Jakob disease 136
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination 136
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 136
Meaningful improvement in walking performance after botulinum neurotoxin A (BoNT-A) in chronic spastic patients 135
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. 134
Frequency of blood-retina and blood-brain barrier changes in multiple sclerosis 134
Enhanced secretion of substance P by cytokine-stimulated rat brain endothelium cultures 133
Long time interval between multiple sclerosis onset and occurrence of primary Sjogren's syndrome in a woman treated with interferon-beta 133
Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients 133
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 133
Certain surface properties of isolated and cultured cerebellar cells. 131
Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice 131
Serum fractions from amyotrophic lateral sclerosis patients depress voltage-activated Ca2+ of rat cerebellar granule cells in culture 130
Stability of lysosomal enzyme activity in post-mortem rat brain 129
Stability of lysosomal enzyme activity in post-mortem rat brain 129
Neurochemical changes in Creutzfeldt-Jakob disease 129
Les glycoconjuguées de membranes dans la maladie de Creutzfeldt-Jakob. 126
Complement alterations in the CSF of patients with amyotrophic lateral sclerosis 123
L'endotelio cerebrale: ruolo nell'immunità. 123
Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis - Results of the βPlus observational cohort study 123
Congenital metachromatic leucodystrophy with severe and persistent muscular hypotonia [Leucodistrofia metacromatica congenita con grave e persistente ipotonia muscolare] 121
High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis 121
Registro toscano e sclerosi multipla: dati preliminari 120
A novel highly selective cannabinoid CB2 agonist reduces in vitro growth and TGF-beta release of human glial cell tumors 116
Established and emerging features of brain vessel inflammation 115
Aggiornamenti sull'eziopatogenesi della Sclerosi multipla. 114
Lessons from the "Euro-Lupus Cohort" 113
Alcune evidenze per un possibile ruolo del sistema immunitario nella patogenesi della Sclerosi laterale amiotrofica. 113
Aspetti biologici dell'interleukina-1. 112
Detection of Borrelia burgdoferi DNA and complement attack complex deposits in the sural nerve of a patient with chronic polyneuropathy and tertiary Lyme disease 111
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. 111
Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1 beta and TNF-alpha 111
Adult dementia in three siblings: ceroid-lipofuscinosis 110
Totale 16.181
Categoria #
all - tutte 48.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.675 0 0 0 0 0 239 250 382 208 323 81 192
2020/20212.002 86 233 61 208 91 231 90 340 252 126 171 113
2021/20221.301 92 186 54 101 47 43 76 54 63 169 144 272
2022/20232.324 139 129 282 311 249 459 56 183 235 134 105 42
2023/20241.385 63 44 116 50 73 334 428 47 12 39 51 128
2024/20251.167 73 164 239 158 400 133 0 0 0 0 0 0
Totale 17.947